📰 Medication Guide News

Page 17 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 1, 2023

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system

New Jersey United States Jersey City Christopher Hansung Ko Samsung Bioepis Kevin Ali

Source: marketscreener.com

A Look Ahead in Life Sciences: What We Are Tracking in Q3 2023 and Beyond | Goodwin

June 30, 2023

As the life sciences industry continues to expand and grow increasingly complex, so does its legal, regulatory, and compliance landscape. To help companies and investors navigate the...

Jeff Shuren Diana Degette Life Sciences Regulatory Compliance Program Administration Office Of Prescription Drug Promotion Department Of Justice

Source: jdsupra.com

Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

June 28, 2023

COPENHAGEN, Denmark--(BUSINESS WIRE)--Jun 27, 2023--

United States New Jersey Hematol Hemoter Marisol Peron Genmab Us Inc Lymphoma Research Foundation

Source: joplinglobe.com

Getting past the pain: One dancer's story of living with nr-axSpA | Health & Wellness

June 27, 2023

Sorry, but your browser does not support the video tag.

United States Spondylitis Association Of America Group Of Companies Ucb Inc Safety Information Tumor Necrosis Factor

Source: yankton.net

10 Most Recent Medical Safety Recalls – 24/7 Wall St.

June 27, 2023

Here are the 10 most recent FDA safety recalls for drugs and medical devices. Several may cause injury or even death if used despite the FDA warnings.

United States Mayne Pharma Major Pharmaceuticals Harvard Drug Group Family Dollar Teva Pharmaceuticals

Source: 247wallst.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AbbVie and Genmab Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

June 27, 2023

/PRNewswire/ -- AbbVie (NYSE: ABBV) and Genmab (Nasdaq: GMAB) today announced topline results from the follicular lymphoma (FL) cohort of the Phase 1/2 EPCORE™...

United States Mariana Cota Stirner Hematol Hemoter Exchange Commission Us Inc Data From The Observational National Lymphocare Study

Source: prnewswire.com